Johnson & Johnson's experimental prostate cancer drug, JNJ-6143, has shown significant tumor shrinkage and reduced PSA levels ...

Zymeworks has entered a global licensing agreement with Roche to develop and commercialize its experimental lung cancer drug ...

A groundbreaking study reveals that Amgen's Imdelltra, when combined with AstraZeneca's immunotherapy Imfinzi, significantly ...

Sun Pharma's Unolxcyt shows a significant objective response rate and durable cancer control for patients with advanced skin ...

Bengaluru: The US FDA's drug evaluation department said on Friday it has formed a board to oversee and advise on exclusivity determinations made by the department, aiming to improve clarity and ...

Mumbai: Lupin announced today the acquisition of Huminsulin, an Insulin indicated for the treatment of both type 1 and type 2 diabetics from Eli Lilly and Company in India for an undisclosed amount.

Dr Reddy's Laboratories has introduced two new generic versions of Ozempic, named Obeda Pro and Obeda Plus, to address supply ...

AbbVie announced promising results for its experimental drug lutikizumab in reducing skin lesions from hidradenitis ...

Telitacicept met the study's main goal and largely preserved kidney function over two years, while patients on placebo saw a ...

The deal follows positive mid-stage results for Gilead's experimental pill for chronic bowel disease, emvistegrast, on Monday ...

Chicago: An mRNA cancer vaccine developed by Moderna and Merck in combination with a widely used immunotherapy cut the risk of death or recurrence of melanoma by 42% and disease spread by 38%, ...